Akari Therapeutics Plc Год IPO
Что обозначает Год IPO в Akari Therapeutics Plc?
Год IPO Akari Therapeutics Plc является 2013
Какое определение для Год IPO?
Первичное публичное размещение акций - это тип публичного предложения, при котором акции компании обычно продаются институциональным инвесторам, которые, в свою очередь, впервые продают эти акции широкой публике на фондовой бирже.
Through IPO a privately held company transforms into a public company. Initial public offerings are mostly used by companies to raise the expansion of capital, possibly to monetize the investments of early private investors, and to become publicly traded enterprises. A company selling shares is never required to repay the capital to its public investors. After the IPO, when shares trade freely in the open market, money passes between public investors.
Although IPO offers many advantages, there are also significant disadvantages, chief among these are the costs associated with the process and the requirement to disclose certain information that could prove helpful to competitors.
The IPO process is colloquially known as going public. Details of the proposed offering are disclosed to potential purchasers in the form of a lengthy document known as a prospectus. Most companies undertake an IPO with the assistance of an investment banking firm acting in the capacity of an underwriter. Underwriters provide several services, including help with correctly assessing the value of shares.
Год IPO компаний в Health Care сектор на NASDAQ по сравнению с Akari Therapeutics Plc
Что делает Akari Therapeutics Plc?
akari is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics to treat orphan autoimmune and inflammatory diseases. akari’s lead drug, coversin, a second-generation and potentially best-in-class complement inhibitor, acts on complement component-c5, preventing release of c5a and formation of c5b – 9 (also known as the membrane attack complex or mac). coversin is a recombinant small protein (16,740 da) derived from a native protein discovered in the saliva of the ornithodoros moubata tick, where it modulates the host immune system to allow the parasite to feed without alerting the host to its presence or provoking an immune response.
Компании с год ipo похож на Akari Therapeutics Plc
- AMG Capital Trust II имеет Год IPO из 2012
- Live Nation Entertainment имеет Год IPO из 2012
- MGM Resorts International имеет Год IPO из 2012
- EnerSpar имеет Год IPO из 2012
- The Western Union имеет Год IPO из 2012
- Wameja имеет Год IPO из 2012
- Akari Therapeutics Plc имеет Год IPO из 2013
- Opus Bank имеет Год IPO из 2014
- Recro Pharma Inc имеет Год IPO из 2014
- Radius Recycling имеет Год IPO из 2014
- Progenity имеет Год IPO из 2014
- Axalta Coating Systems Ltd имеет Год IPO из 2014
- Anevia SA имеет Год IPO из 2014